伊索奥林丁:揭示隐藏的黄类药物对抗癌症发展和进展的潜力 - - 综合性综述
Lucas Fornari Laurindo1, Karina Torres Pomini2, Enzo Pereira de Lima3
1Department of Biochemistry and Pharmacology, School of Medicine, Faculdade de Medicina de Marília (FAMEMA), Marília 17519-030, São Paulo, Brazil; Department of Biochemistry and Pharmacology, School of Medicine, Universidade de Marília (UNIMAR), Marília 17525-902, São Paulo, Brazil; Department of Administration, Associate Degree in Hospital Management, Universidade de Marília (UNIMAR), Marília 17525-902, São Paulo, Brazil.
Life sciences
|November 28, 2024
概括
一种天然的黄类化合物异素 (ISO) 通过抑制细胞生长和扩散,显示出对抗癌症的前途. 对这种化合物的进一步研究可能会导致新的,有效的癌症治疗方法.
科学领域:
- * 药理学与自然产品
- * 瘤学 在线咨询
- * 分子生物学 * 分子生物学
背景情况:
- * 癌症是全球主要的死亡原因,治疗疗效和副作用存在持续挑战.
- *新型治疗剂对于选择性向癌细胞和改善治疗结果至关重要.
- * 一种黄类化合物异素 (ISO) 具有已知的抗癌特性,影响关键的癌症进展途径.
研究的目的:
- * 对Isoorientin抗癌作用的体外研究进行审查.
- * 了解ISO对各种癌症类型的作用机制.
- * 评估ISO作为一种新型治疗剂的潜力.
主要方法:
- * 对Isoorientin和癌症的体外研究进行全面的文献搜索.
- *分析了13项针对不同癌细胞系的研究结果.
- *对结果的评估,包括细胞活力,细胞亡,迁移和分子通路调节.
主要成果:
- * 在实验室中,异丁在肺癌,脑癌,口腔癌,肝癌,胰腺癌和胃癌中表现出显著的抗癌作用.
- *ISO影响了关键的癌症过程,如扩散,亡和转移.
- *观察到分子通路调制,表明了特定的作用机制.
结论:
- * 基于体外证据,异源素具有广泛的抗癌潜力.
- *ISO影响癌症关键特征的能力需要进一步研究.
- * 本综述综合了当前的知识,强调ISO作为未来癌症治疗开发的有希望的候选人.
更多相关视频
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


